期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

《化学科学与工程前沿(英文)》 >> 2014年 第8卷 第3期 doi: 10.1007/s11705-014-1426-x

Controlled drug delivery systems: the next 30 years

Departments of Biomedical Engineering and Pharmaceutics, Purdue University, West Lafayette, IN 47907, USA

发布日期: 2014-10-11

下一篇 上一篇

摘要

The drug delivery scientists need to reexamine the advances made during the past 60 years, analyze our current abilities, and design the future technologies that will propel us to achieve the next level of drug delivery technologies. History shows that the first generation (1G) of drug delivery research during 1950–1980 was quite productive, while the second generation (2G) technologies developed during 1980–2010 were not as prolific. The ultimate goal of drug delivery research is to develop clinically useful formulations to treat various diseases. Effective drug delivery systems can be developed by overcoming formulation barriers and/or biological barriers. The engineering approach has a limit in solving the problem, if biological difficulties are not clearly identified and understood. The third generation (3G) drug delivery systems will have to focus on understanding the biological barriers so that they can be overcome by engineering manipulation of the drug delivery systems. Advances in the next 30 years will be most accelerated by starting open dialogues without any preconceived ideas on drug delivery technologies. The new generation of drug delivery scientists needs to be aware of the successes and limitations of the existing technologies to design the new technologies for meaningful advances in the future.

相关研究